GTHX - G1 Pharma Growth-Adjusted Payback Ratio

Symbol and logo of brand G1 Therapeutics, Inc. (GTHX)

The PEG ratio for G1 Therapeutics, Inc. (GTHX) reflects the impact of bone marrow protection and expansion across Asia and Europe. Partnerships with distributors are accelerating the global rollout of drugs, yet a revenue shortfall coupled with high R&D expenses is depleting capital. This metric's trend has reached the 0.00 level, allowing for a real-time assessment of the business value relative to its growth rates.

GTHX G1 Pharma Price/Earnings to Growth Ratio (07/04/2022 - 09/28/2024)

Metric breakdowns and analytics for G1 Therapeutics, Inc. (GTHX)

- current price and projected stock value:
- market capitalization statistics:
Fundamental company analysis:G1 Therapeutics, Inc. GTHX
Original product of G1 Pharma

This indicator compares the market value of G1 Therapeutics, Inc. (GTHX) with its earnings growth rate, where a value below one signals that the asset is undervalued relative to its expansion. By analyzing the P/E ratio in conjunction with EPS growth, an investor can see how the synergy with PharmaEssentia and the protection of the drug Cosela create a foundation for earnings acceleration, turning local dips on the chart into entry points.